Interaction of isoflurane and sevoflurane with α- and β-adrenoceptor stimulations in rat myocardium

Anesthesiology

Volumn 88, Issue 5, 1998, Pages 1249-1258

  Hanouz, Jean Luc ^a   Vivien, Benoît ^b   Gueugniaud, Pierre Yves ^c   Lecarpentier, Yves ^d,e   Coriat, Pierre ^b   Riou, Bruno ^b  

^a Department of Anesthesiology

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d INSERM   (France)

^e BICÊTRE HOSPITAL   (France)

Author keywords

Contractility; Heart; Papillary muscle; Relaxation; Volatile anesthesia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; FORTEC; ISOFLURANE; ISOPRENALINE; PHENTOLAMINE; PHENYLEPHRINE; PROPRANOLOL; SEVOFLURANE; UNCLASSIFIED DRUG;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INOTROPISM; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANESTHETICS, INHALATION; ANIMALS; CARDIOTONIC AGENTS; DRUG SYNERGISM; HEART; ISOFLURANE; ISOPROTERENOL; MALE; METHYL ETHERS; MYOCARDIAL CONTRACTION; PHENYLEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA;

EID: 0031955862     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199805000-00016     Document Type: Article

References (36)

1. Böhm M, Schmidt U, Schwinger RHG, Böhm S, Erdmann E: Effects of halothane on beta-adrenoceptors and M-cholinoceptors in human myocardium: radiolignad and functional studies. J Cardiovasc Pharmacol 1993; 21:296-304
2. Hanouz JL, Riou B, Massias L, Lecarpentier Y, Coriat P: Interaction of halothane with α- and α-adrenoceptor stimulations in rat myocardium. ANESTHESIOLOGY 1997; 86:147-59
3. Yost CS: G protein: Basic characteristics and clinical potential for the practice of anesthesia. Anesth Analg 1993; 77:822-34
4. Vulliemoz Y, Verosky M: Halothane interaction with guanine nucleotide binding proteins in mouse heart. ANESTHESIOLOGY 1988; 69:876-80
5. Rooney TA, Hager R, Stubbs CD, Thomas AP: Halothane regulates G-protein-dependent phospholipase C activity in turkey erythrocyte membranes. J Biol Chem 1993; 268:15550-6
6. Schmidt U, Schwinger RHG, Böhm M: Interaction of halothane with inhibitory G-proteins in the human myocardium. ANESTHESIOLOGY 1996; 83:353-60
7. Eger EI II: New inhaled anesthetics. ANESTHESIOLOGY 1994; 80:906-22
8. Sanuki M, Yuge O, Kawamoto M, Fujii K, Azuma T: Sevoflurane inhibited β-adrenoceptor-G protein bindings in myocardial membrane in rats. Anesth Analg 1994; 79:466-71
9. Lennon PF, Murray PA: Isoflurane and the pulmonary vascular pressure-flow relation at baseline and during sympathetic α- and βadrenoceptor activation in chronically instrumented dogs. ANESTHESIOLOGY 1995; 82:723-33
10. Coudray N, Beregi JP, Lecarpentier Y, Chemla D: Effects of isoproterenol on myocardial relaxation rate: Influence of the level of load. Am J Physiol 1993; 265:H1645-53
11. Wheeler DM, Katz A, Rice RT, Hansford RG: Volatile anesthetic effects on sarcoplasmic reticulum Ca content and sarcolemmal Ca flux in isolated rat cardiac cell suspensions. ANESTHESIOLOGY 1994; 80:372-82
12. Hanouz JL, Vivien B, Gueugniaud PY, Riou B, Coriat P. Inotropic and lusitropic effects of sevoflurane in rat myocardium [Abstract]. Br J Anaesth 1997; 78(suppl 1):44
13. Riou B, Lecarpentier Y, Viars P: In vitro effects of ketamine on rat cardiac papillary muscle. ANESTHESIOLOGY 1989; 71:116-25
14. Mazze RI, Rice SA, Baden JM: Halothane, isoflurane, and enflurane MAC in pregnant and non pregnant female and male mice and rats. ANESTHESIOLOGY 1985; 62:339-41
15. Vitez TS, White PF, Eger El II: Effects of hypothermia on halothane and isoflurane MAC in the rat. ANESTHESIOLOGY 1974; 41:80-2
16. Park WK, Pancrazio JJ, Suh CH, Lynch C III: Myocardial depressant effects of sevoflurane. Mechanical and electrophysiological actions in vitro. ANESTHESIOLOGY 1996; 84:1166-76
17. Lecarpentier Y, Martin JL, Gastineau P, Hatt PY: Load dependence of mammalian heart relaxation during cardiac hypertrophy and heart failure. Am J Physiol 1982; 242:H855-61
18. Brutsaert DL, Claes VA: Onset of mechanical activation of mammalian heart muscle in calcium- and strontium-containing solutions. Circ Res 1974; 35:345-57
19. Chemla D, Lecarpentier Y, Martin JL, Clergue M, Antonetti A, Halt PY: Relationship between inotropy and relaxation in rat myocardium. Am J Physiol 1986; 250:H1008-16
20. Lecarpentier YC, Martin JL, Claes V, Chambaret JP, Migus A, Antonetti A, Hatt PY: Real-time kinetics of sarcomere relaxation by laser diffraction. Circ Res 1985; 56:331-9
21. Housmans PR, Lee NKM, Blinks JR: Active shortening retards the decline of intracellular calcium transient in mammalian heart muscle. Science 1983; 221:159-61
22. Böhm M, Schmidt U, Gierschik P, Schwinger RHG, Bohm S, Erdmann E: Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type cells: Evidence for an inactivation of the inhibitory G protein (Gia). Mol Pharmacol 1994; 45:380-9
23. Park KW, Dai HB, Lowenstein E, Darvish A, Sellke FW: Isoflurane attenuates cAMP-mediated vasodilation in rat microvessels. Circulation 1995; 92(suppl II):II-423-7
24. Hayashi Y, Sumikawa K, Yamotodani A, Kamibayashi T, Kuro M, Yoshiya I: Myocardial epincphrine sensitization with subanesthetic doses of halothane in dogs. ANESTHESIOLOGY 1991; 74:134-7
25. Stowe DF, Dujic Z, Bosnjak ZJ, Kalbfleisch JH, Kampine JP: Volatile anesthetics attenuate sympathomimetic actions on the Guinea pig SA node. ANESTHESIOLOGY 1988; 68:887-94
26. Bazan A, Van De Velde E, Fraeyman N: Effect of age on β-receptor, Gand G-proteins in rat heart. Biochem Pharmacol 1994; 48:479-86
27. Böhm M, Eschenhagen T, Gierschik P, Larisch K, Lensche H, Mende U, Schmitz W, Schnabel P, Scholz H, Steinfath M, Erdmann E: Radioimmunochemical quantification of G in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J Moll Cell Cardiol 1994; 26:133-49
28. Johnston RR, Eger EI, Wilson C: A comparative interaction of epinephrine with enflurane and halothane in man. Anesth Analg 1976; 55:709-12
29. Anthony BL, Dennison RL, Aronstam RS: Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett 1989; 99:191-6
30. 2+ release channel of cardiac sarcoplasmic reticulum by volatile anesthetics. ANESTHESIOLOGY 1994; 81:459-69
31. Lynch C, Frazer MJ: Anesthetic alteration of ryanodine binding by cardiac calcium release channels. Biochim Biophys Acta 1994; 1194:109-17
32. Grossman W: Diastolic dysfunction in congestive heart failure. N Engl J Med 1991; 325:1557-64
33. 2+ currents in cardiac ventricular myocytes. Circ Res 1996; 79:184-93
34. Paradise NF, Schmitter JL, Surmitis JM: Criteria for adequate oxygenation of isometric kitten papillary muscle. Am J Physiol 1981; 241:H348-53
35. Steinfath M, Chen YY, Lavicky J, Magnussen O, Nose M, Rosswag S, Schmitz W, Scholz H: Cardiac α1-adrenoceptor densities in different mammalian species. Br J Pharmacol 1992; 107:185-8
36. Sen L, Liang BT, Colucci WS, Smith TW: Enhanced α1-adrenergic responsiveness in cardiomyopathic hamster cardiac myocytes. Circ Res 1990; 67:1182-92